Wang D, Wang C, Liu L, Li S (2018)
Protective effects of evodiamine in experimental paradigm of Alzheimer's disease
Cogn Neurodyn 12: 303

Zhang Y, Wang J, Wang C, Li Z, Liu X, Zhang J, Lu J, Wang D (2018)
Pharmacological Basis for the Use of Evodiamine in Alzheimer's Disease: Antioxidation and Antiapoptosis
Int J Mol Sci 19:

Huang G, Kling B, Darras FH, Heilmann J, Decker M (2014)
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine
Eur Journal of Medicinal Chemistry 81C: 15

Decker M (2005)
Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine
Eur Journal of Medicinal Chemistry 40: 305

Wang HH, Chou CJ, Liao JF, Chen CF (2001)
Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice
European Journal of Pharmacology 413: 221

Park CH, Kim SH, Choi W, Lee YJ, Kim JS, Kang SS, Suh YH (1996)
Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa
Planta Med 62: 405